Maze Therapeutics (MAZE) Stock Chart & Stock Price History $23.30 -1.50 (-6.05%) As of 09/12/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 74.53%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $23.30 with a market cap of $1.02 billion and volume of 1.27 million shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+42.59%1 Month Performance+74.53%3 Month Performance+73.88% MAZE Stock Chart for Sunday, September, 14, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/12/2025$24.80$23.30-6.05%$25.48$22.011.27 million shs$1.02 billion09/11/2025$16.02$24.80+54.81%$25.50$20.005.07 million shs$1.09 billion09/10/2025$16.34$16.02-1.96%$17.45$15.70300,947 shs$702.49 million09/09/2025$14.97$16.34+9.15%$17.07$14.75473,258 shs$716.51 million09/08/2025$15.88$14.97-5.73%$16.05$14.90270,202 shs$656.43 million09/05/2025$15.04$15.88+5.59%$16.20$14.27309,623 shs$696.34 million09/04/2025$15.19$15.04-0.99%$15.68$14.16354,913 shs$659.52 million09/03/2025$15.32$15.19-0.85%$16.40$14.86390,311 shs$666.08 million09/02/2025$14.49$15.32+5.73%$15.60$14.44513,675 shs$671.78 million09/01/2025$14.49$14.49$14.85$13.89358,404 shs$635.40 million Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/29/2025$14.27$14.49+1.54%$14.85$13.89358,404 shs$635.40 million08/28/2025$13.87$14.27+2.88%$14.39$13.781.26 million shs$625.74 million08/27/2025$14.05$13.87-1.28%$14.76$13.67430,233 shs$608.20 million08/26/2025$13.31$14.05+5.56%$14.62$13.28550,319 shs$616.11 million08/25/2025$13.49$13.31-1.33%$13.54$12.91234,956 shs$583.64 million08/22/2025$13.23$13.49+1.97%$14.02$13.30263,956 shs$591.54 million08/21/2025$13.48$13.23-1.85%$13.93$13.00192,252 shs$580.14 million08/20/2025$13.45$13.48+0.22%$14.01$13.24476,471 shs$591.11 million08/19/2025$13.35$13.45+0.75%$13.75$12.81214,992 shs$589.78 million08/18/2025$13.50$13.35-1.11%$13.92$13.20140,316 shs$585.40 million08/15/2025$13.35$13.50+1.12%$13.58$12.86136,553 shs$591.98 million08/14/2025$13.60$13.35-1.84%$13.59$13.00101,096 shs$584.69 million08/13/2025$13.74$13.60-1.02%$14.56$13.16299,055 shs$595.68 million Related Companies ACADIA Pharmaceuticals Stock Chart ADMA Biologics Stock Chart Ascentage Pharma Group International Stock Chart Metsera Stock Chart Lantheus Stock Chart Mirum Pharmaceuticals Stock Chart Protagonist Therapeutics Stock Chart Zai Lab Stock Chart Akero Therapeutics Stock Chart MoonLake Immunotherapeutics Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MAZE Stock Alerts